{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:10:02Z","timestamp":1741695002849,"version":"3.38.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.yrtph.2025.105798","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:49:13Z","timestamp":1740728953000},"page":"105798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days"],"prefix":"10.1016","volume":"158","author":[{"given":"Jorge","family":"Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherwin","family":"Silo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Hum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocky","family":"DiFruscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Thouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizet","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Berlanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Berryman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Ministerio de Salud P\u00fablica","key":"10.1016\/j.yrtph.2025.105798_bib1"},{"issue":"5","key":"10.1016\/j.yrtph.2025.105798_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/026119291304100504","article-title":"An analysis of the use of dogs in predicting human toxicology and drug safety","volume":"41","author":"Bailey","year":"2013","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2025.105798_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1330425","article-title":"Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature","volume":"113","author":"Bellone","year":"1995","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.yrtph.2025.105798_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/CS20060103","article-title":"Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction","volume":"112","author":"Berlanga","year":"2007","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yrtph.2025.105798_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/CS20060103","article-title":"Prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction","volume":"112","author":"Berlanga","year":"2007","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2025.105798_bib6","first-page":"60","article-title":"Growth Hormone Releasing Peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats","volume":"29","author":"Berlanga-Acosta","year":"2012","journal-title":"Biotecnol. Apl."},{"issue":"4","key":"10.1016\/j.yrtph.2025.105798_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF03343555","article-title":"Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans","volume":"22","author":"Bisi","year":"1999","journal-title":"J. Endocrinol. Investig."},{"issue":"6","key":"10.1016\/j.yrtph.2025.105798_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/10915818221125670","article-title":"The dog as a second species for toxicology testing provides value to drug development","volume":"41","author":"Bower","year":"2022","journal-title":"Int. J. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2025.105798_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/endo-114-5-1537","article-title":"On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone","volume":"114","author":"Bowers","year":"1984","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.yrtph.2025.105798_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0143-4160(94)90064-7","article-title":"GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs","volume":"15","author":"Bresson-B\u00e9poldin","year":"1994","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/ENDO:14:1:105","article-title":"Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy","volume":"14","author":"Broglio","year":"2001","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.yrtph.2025.105798_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejps.2012.10.006","article-title":"Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers","volume":"48","author":"Cabrales","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.yrtph.2025.105798_bib14","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2015 on CDC WONDER Online Database, released December 2016. Data are from the Multiple Cause of Death Files, 1999-2015, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed at http:\/\/wonder.cdc.gov\/mcd-icd10.html."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-9556(25)08313-8","article-title":"Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administration","volume":"22","author":"Davis","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2025.105798_bib16","series-title":"Principles and Methods of Toxicology","first-page":"864","author":"DiPasquale","year":"2001"},{"issue":"5","key":"10.1016\/j.yrtph.2025.105798_bib17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/en.2009-1394","article-title":"The positive effects of growth hormone-releasing peptide-6 on weight gain and fat mass accrual depend on the insulin\/glucose status","volume":"151","author":"Granado","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2025.105798_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.02.002","article-title":"Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats","volume":"337","author":"Granado","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yrtph.2025.105798_bib19","unstructured":"Guide for the care and use of laboratory animals. eighth ed. Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life Studies. THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001."},{"issue":"6","key":"10.1016\/j.yrtph.2025.105798_bib20","first-page":"1378","article-title":"Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men","volume":"74","author":"Hartman","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2025.105798_bib21","unstructured":"https:\/\/rpcec.sld.cu\/en\/trials\/RPCEC00000177-En. Cuban Public Registry of clinical trials. Primary registry: RPCEC. Unique ID number: RPCEC00000177."},{"key":"10.1016\/j.yrtph.2025.105798_bib22","unstructured":"https:\/\/www.msdvetmanual.com\/immune-system\/immunologic-diseases\/hypersensitivity-diseases-in-animals.IanRodneyTizard.HypersensitivityDiseasesinAnimals."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib23","article-title":"Growth hormone releasing hexapeptide-6 (GHRP-6): possible protective role against experimentally-induced osteoporosis in female albino rats","volume":"32","author":"Ibrahim","year":"2012","journal-title":"Bull. Egypt. Soc. Physiol. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2003.10.012","article-title":"Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters","volume":"61","author":"Iwase","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib25","first-page":"81","article-title":"Clinical safety of growth hormone-releasing peptide 6 (GHRP-6) in healthy volunteers","volume":"6","author":"Katty-Hind Selman-Housein","year":"2014","journal-title":"Invest Medicoquir"},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib26","first-page":"81","article-title":"Seguridad cl\u00ednica del p\u00e9ptido liberador de la hormona de crecimiento-6 (GHRP-6) en voluntarios sanos","volume":"6","author":"Katty-Hind Selman-Housein","year":"2014","journal-title":"Invest Medicoquir"},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/jme.0.0140135","article-title":"Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells","volume":"14","author":"Lei","year":"1995","journal-title":"J. Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.yrtph.2025.105798_bib28","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/endo.140.9.6948","article-title":"Growth hormone-independent cardioprotective effects of hexarelin in the rat","volume":"140","author":"Locatelli","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2025.105798_bib29","series-title":"Staining Methods, Histologic and Histochemical","first-page":"123","author":"MacMagnus","year":"1968"},{"issue":"2","key":"10.1016\/j.yrtph.2025.105798_bib30","first-page":"2501","article-title":"GHRP-6, a novel candidate for prevention and treatment of fibrotic disorders","volume":"34","author":"Mendoza-Mar\u00ed","year":"2017","journal-title":"Biotecnol. Apl."},{"issue":"16","key":"10.1016\/j.yrtph.2025.105798_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/vr.116.16.431","article-title":"Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment","volume":"116","author":"Morton","year":"1985","journal-title":"Vet. Rec."},{"issue":"4","key":"10.1016\/j.yrtph.2025.105798_bib32","first-page":"1186","article-title":"Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation","volume":"83","author":"Pandya","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2025.105798_bib33","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00001756-200308260-00018","article-title":"Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats","volume":"14","author":"Paneda","year":"2003","journal-title":"Neuroreport"},{"issue":"9236","key":"10.1016\/j.yrtph.2025.105798_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(00)02755-0","article-title":"GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults","volume":"356","author":"Popovic","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.yrtph.2025.105798_bib35","article-title":"Role of epidermal growth factor and growth hormone-releasing peptide-6 in acceleration of renal tissue repair after kanamycin overdosing in rats","volume":"8","author":"Rodriguez Salgueiro","year":"2014","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/fishes7010031","article-title":"Feed supplementation with the GHRP-6 peptide, a ghrelin analog, improves feed intake, growth performance and aerobic metabolism in the gilthead sea bream Sparus aurata","volume":"7","author":"Rodr\u00edguez-Viera","year":"2022","journal-title":"Fishes"},{"issue":"3","key":"10.1016\/j.yrtph.2025.105798_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/jomfp.JOMFP_14_15","article-title":"Kerosene: contributing agent to xylene as a clearing agent in tissue processing","volume":"21","author":"Shah","year":"2017","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"2","key":"10.1016\/j.yrtph.2025.105798_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.103.050997","article-title":"A growth hormone secretagogue prevents ischemic-induced mortality independently of the growth hormone pathway in dogs with chronic dilated cardiomyopathy","volume":"306","author":"Shen","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105798_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/endo.141.1.7249","article-title":"The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction","volume":"141","author":"Tivesten","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2025.105798_bib40","first-page":"285","article-title":"Cardiotropic effect of GHRP-6: in vivo characterization by echocardiography","volume":"30","author":"Valiente","year":"2013","journal-title":"Biotecnol. Apl."},{"year":"2019","series-title":"Testing Guide for Growth Hormone Releasing Factors (GHRFs) V2","key":"10.1016\/j.yrtph.2025.105798_bib41"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:55:01Z","timestamp":1741694101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230025000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"alternative-id":["S0273230025000285"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105798","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105798"}}